{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:19Z","timestamp":1786985419116,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bmc.2023.117258","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T21:55:55Z","timestamp":1679522155000},"page":"117258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1083-7034","authenticated-orcid":false,"given":"Willem F.J.","family":"Karstens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiro","family":"M.B.P. Menge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne J.N.","family":"op het Veld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Th.H. van Eupen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Demon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja A.E.","family":"van Achterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica J.","family":"Arisse-Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen W.H.","family":"Santegoeds-Lenssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda M.C.","family":"van der Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Ubink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel J.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloys","family":"Sesink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9408-7412","authenticated-orcid":false,"given":"Marion","family":"Blomenr\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marco Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117258_b0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2008-0044","article-title":"Thyrotropin and homologous glycoprotein hormone receptors: Structural and functional aspects of extracellular signaling mechanisms","volume":"30","author":"Kleinau","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bmc.2023.117258_b0010","first-page":"673","article-title":"The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bmc.2023.117258_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.bmc.2023.117258_b0020","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","article-title":"Management of Graves\u2019 Thyroidal and Extrathyroidal Disease: An Update","volume":"105","author":"Kahaly","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bmc.2023.117258_b0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J."},{"key":"10.1016\/j.bmc.2023.117258_b0030","doi-asserted-by":"crossref","unstructured":"Lee ACH, Kahaly GJ. Pathophysiology of thyroid-associated orbitopathy. Best Pract Res Clin Endocrinol Metab. Published online February 5, 2022:101620. doi:10.1016\/j.beem.2022.101620.","DOI":"10.1016\/j.beem.2022.101620"},{"key":"10.1016\/j.bmc.2023.117258_b0035","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bmc.2023.117258_b0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/17446651.2022.2052044","article-title":"Management of Graves\u2019 hyperthyroidism: present and future","volume":"17","author":"Bartalena","year":"2022","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.bmc.2023.117258_b0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/14728222.2015.1018181","article-title":"Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies","volume":"19","author":"Davies","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmc.2023.117258_b0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/en.2013-1835","article-title":"A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice","volume":"155","author":"Neumann","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bmc.2023.117258_b0055","first-page":"7(SEP)","article-title":"TSH receptor signaling abrogation by a novel small molecule","author":"Latif","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bmc.2023.117258_b0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/thy.2018.0349","article-title":"A new highly thyrotropin receptor-selective small-molecule antagonist with potential for the treatment of graves\u2019 orbitopathy","volume":"29","author":"Marcinkowski","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.bmc.2023.117258_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1134\/S1607672920020064","article-title":"New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone","volume":"491","author":"Derkach","year":"2020","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.bmc.2023.117258_b0070","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/j.1476-5381.2011.01709.x","article-title":"Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor","volume":"165","author":"Van Koppen","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117258_b0075","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1210\/jc.2011-2931","article-title":"Complete inhibition of rhTSH-, Graves\u2019 disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist","volume":"97","author":"Van Zeijl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bmc.2023.117258_b0080","doi-asserted-by":"crossref","unstructured":"Latif R, Morshed SA, Ma R, Tokat B, Mezei M, Davies TF. A Gq Biased Small Molecule Active at the TSH Receptor. Front Endocrinol (Lausanne). 2020;11(June):Article 372. doi:10.3389\/fendo.2020.00372.","DOI":"10.3389\/fendo.2020.00372"},{"key":"10.1016\/j.bmc.2023.117258_b0085","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1021\/jo980072x","article-title":"Synthesis of 2\u2018-Alkylspiro[2-X-cyclohexan-1,3\u2018-3\u2018H-indole] (X = H; X = CH3) by an Unexpected Reaction between an Organomagnesium Halide and 2\u2018-Methylspiro[2-X-cyclohexan-1,3\u2018-3\u2018H-indole]. X-ray Structure of a Fluorescent Dimeric Compound","volume":"63","author":"Rodr\u00edguez","year":"1998","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117258_b0090","doi-asserted-by":"crossref","first-page":"14224","DOI":"10.1021\/jacs.7b07344","article-title":"Lewis Acid Enabled Copper-Catalyzed Asymmetric Synthesis of Chiral \u03b2-Substituted Amides","volume":"139","author":"Rodr\u00edguez-Fern\u00e1ndez","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117258_b0095","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1021\/ja206427u","article-title":"Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2","volume":"133","author":"Shamovsky","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117258_b0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/op100251q","article-title":"Second-Generation Process Research Towards Eletriptan: A Fischer Indole Approach","volume":"15","author":"Ashcroft","year":"2011","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.bmc.2023.117258_b0105","doi-asserted-by":"crossref","DOI":"10.1055\/s-0040-1719865","article-title":"General, and Regioselective Synthesis of 2-Aminopyridines from Pyridine N -Oxides via N -(2-Pyridyl)pyridinium Salts","volume":"33","author":"Xiong","year":"2022","journal-title":"Synlett"},{"key":"10.1016\/j.bmc.2023.117258_b0110","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/jm020578e","article-title":"Structure-Based Design of Novel Guanidine\/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants","volume":"46","author":"Lam","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117258_b0115","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0960-894X(02)00234-2","article-title":"Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors","volume":"12","author":"Zhang","year":"2002","journal-title":"Bioorganic Med Chem Lett."},{"key":"10.1016\/j.bmc.2023.117258_b0120","doi-asserted-by":"crossref","first-page":"48848","DOI":"10.1039\/C7RA09165F","article-title":"Development of a metal-free amine oxidation method utilizing DEAD chemistry","volume":"7","author":"Wang","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117258_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/chem.201400284","article-title":"Regioselective hydroarylation reactions of C3 electrophilic N-acetylindoles activated by FeCl3: An entry to 3-(Hetero)arylindolines","volume":"20","author":"Beaud","year":"2014","journal-title":"Chem - A Eur J."},{"key":"10.1016\/j.bmc.2023.117258_b0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/acsmedchemlett.6b00022","article-title":"2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8\/19","volume":"7","author":"Mallinger","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117258_b0135","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1021\/jo00042a037","article-title":"Tertiary carbinamines by addition of organocerium reagents to nitriles and ketimines","volume":"57","author":"Ciganek","year":"1992","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117258_b0140","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1021\/acs.orglett.5b02098","article-title":"Access to Highly Substituted 7-Azaindoles from 2-Fluoropyridines via 7-Azaindoline Intermediates","volume":"17","author":"Nuhant","year":"2015","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2023.117258_b0145","first-page":"173","article-title":"Revised methods for the Salmonella mutagenicity test","volume":"113","author":"Maron","year":"1983","journal-title":"Mutat Res Mutagen Relat Subj."},{"key":"10.1016\/j.bmc.2023.117258_b0150","article-title":"471: Bacterial Reverse Mutation Test","author":"No","year":"2020","journal-title":"OECD"},{"key":"10.1016\/j.bmc.2023.117258_b0155","doi-asserted-by":"crossref","unstructured":"Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the salmonella\/mammalian-microsome mutagenicity test. Mutat Res Mutagen Relat Subj. 1975;31(6). doi:10.1016\/0165-1161(75)90046-1.","DOI":"10.1016\/0165-1161(75)90046-1"},{"key":"10.1016\/j.bmc.2023.117258_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1383-5742(97)00019-7","article-title":"Review of mutagenicity of monocyclic aromatic amines: quantitative structure\u2013activity relationships","volume":"387","author":"Chung","year":"1997","journal-title":"Mutat Res Mutat Res."},{"key":"10.1016\/j.bmc.2023.117258_b0165","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1021\/acs.jmedchem.5b01995","article-title":"Structure-Based Design of an Iminoheterocyclic \u03b2-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central A\u03b2 in Nonhuman Primates","volume":"59","author":"Mandal","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117258_b0170","doi-asserted-by":"crossref","unstructured":"Butters M, Ebbs J, P. Green S, et al. Process Development of Voriconazole: A Novel Broad-Spectrum Triazole Antifungal Agent. Org Process Res & Dev. 2000;5(1):28-36. doi:10.1021\/op0000879.","DOI":"10.1021\/op0000879"},{"key":"10.1016\/j.bmc.2023.117258_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-1980-28939","article-title":"A new synthesis of diacylamines","volume":"1980","author":"Lin","year":"1980","journal-title":"Synth."},{"key":"10.1016\/j.bmc.2023.117258_b0180","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic Carbamates in Drug Design and Medicinal Chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117258_b0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(03)13866-4","article-title":"Human monoclonal thyroid stimulating autoantibody","volume":"362","author":"Sanders","year":"2003","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.bmc.2023.117258_b0190","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/1050725041692918","article-title":"Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: Sequence structure and function","volume":"14","author":"Sanders","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.bmc.2023.117258_b0195","unstructured":"Kahaly GJ, Steiner L, van der Lee MMC, et al. Thyrotropin receptor antagonism by a novel small molecule: pre-clinical observations. Thyroid. submitted."},{"key":"10.1016\/j.bmc.2023.117258_b0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13317-011-0025-9","article-title":"In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1\u201370)","volume":"3","author":"Furmaniak","year":"2012","journal-title":"Autoimmun Highlights."}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:21:45Z","timestamp":1760836905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"alternative-id":["S0968089623001062"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117258","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117258"}}